[go: up one dir, main page]

ATE336990T1 - 2-indanylaminoderivate zur therapie von chronischen, akuten oder entzündlichen schmerzen - Google Patents

2-indanylaminoderivate zur therapie von chronischen, akuten oder entzündlichen schmerzen

Info

Publication number
ATE336990T1
ATE336990T1 AT01130638T AT01130638T ATE336990T1 AT E336990 T1 ATE336990 T1 AT E336990T1 AT 01130638 T AT01130638 T AT 01130638T AT 01130638 T AT01130638 T AT 01130638T AT E336990 T1 ATE336990 T1 AT E336990T1
Authority
AT
Austria
Prior art keywords
indanylamino
treatment
derivatives
chronic
acute
Prior art date
Application number
AT01130638T
Other languages
English (en)
Inventor
Claudio Pietra
Gino Villetti
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of ATE336990T1 publication Critical patent/ATE336990T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01130638T 2001-12-21 2001-12-21 2-indanylaminoderivate zur therapie von chronischen, akuten oder entzündlichen schmerzen ATE336990T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01130638A EP1321139B1 (de) 2001-12-21 2001-12-21 2-Indanylaminoderivate zur Therapie von chronischen, akuten oder entzündlichen Schmerzen

Publications (1)

Publication Number Publication Date
ATE336990T1 true ATE336990T1 (de) 2006-09-15

Family

ID=8179649

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01130638T ATE336990T1 (de) 2001-12-21 2001-12-21 2-indanylaminoderivate zur therapie von chronischen, akuten oder entzündlichen schmerzen

Country Status (18)

Country Link
US (1) US20050222266A1 (de)
EP (2) EP1321139B1 (de)
JP (1) JP4427329B2 (de)
AT (1) ATE336990T1 (de)
BR (1) BR0207371A (de)
CA (1) CA2470990C (de)
DE (1) DE60122541T2 (de)
DK (1) DK1321139T3 (de)
ES (1) ES2270947T3 (de)
HU (1) HUP0402664A3 (de)
MX (1) MXPA04005884A (de)
NO (1) NO20033670L (de)
NZ (1) NZ533537A (de)
PL (1) PL207015B1 (de)
PT (1) PT1321139E (de)
SI (1) SI1321139T1 (de)
WO (1) WO2003053429A2 (de)
ZA (1) ZA200404845B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2616659A1 (en) * 2005-07-28 2007-02-15 Chiesi Farmaceutici S.P.A. Therapeutic combination comprising a nmda receptors blocker and a narcotic analgesic substance
US8865741B2 (en) 2011-02-18 2014-10-21 Asana Biosciences, Llc Aminoindane compounds and use thereof in treating pain
WO2014028675A1 (en) 2012-08-15 2014-02-20 Endo Pharmaceuticals Inc. Use of aminoindane compounds in treating overactive bladder and interstitial cystitis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2115792C (en) * 1993-03-05 2005-11-01 David J. Mayer Method for the treatment of pain
IT1283489B1 (it) * 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
EP0980247A1 (de) * 1997-05-07 2000-02-23 Algos Pharmaceutical Corporation Zusammensetzung und behandlung aus kombinationen von antidepressivamit einem nmda rezeptor antagonist, für neuropatische schmerzen
MXPA01012632A (es) * 1999-06-10 2004-03-19 Bridge Pharma Inc Agentes para la anestesia dermica.

Also Published As

Publication number Publication date
CA2470990A1 (en) 2003-07-03
HUP0402664A3 (en) 2012-05-29
AU2002366727A1 (en) 2003-07-09
ZA200404845B (en) 2006-07-26
HUP0402664A2 (hu) 2005-04-28
PL370763A1 (en) 2005-05-30
NO20033670D0 (no) 2003-08-19
EP1455771A2 (de) 2004-09-15
DE60122541T2 (de) 2007-09-13
SI1321139T1 (sl) 2007-02-28
EP1455771B1 (de) 2006-11-08
WO2003053429A2 (en) 2003-07-03
EP1321139A1 (de) 2003-06-25
US20050222266A1 (en) 2005-10-06
BR0207371A (pt) 2004-02-10
DE60122541D1 (de) 2006-10-05
JP4427329B2 (ja) 2010-03-03
MXPA04005884A (es) 2004-11-01
JP2005513101A (ja) 2005-05-12
PL207015B1 (pl) 2010-10-29
CA2470990C (en) 2011-03-29
NZ533537A (en) 2006-08-31
PT1321139E (pt) 2007-01-31
EP1321139B1 (de) 2006-08-23
WO2003053429A3 (en) 2003-07-31
NO20033670L (no) 2003-10-21
DK1321139T3 (da) 2007-01-02
ES2270947T3 (es) 2007-04-16

Similar Documents

Publication Publication Date Title
DE60323077D1 (de) Immobilisierung und stabilisierung von viren
EA200201012A1 (ru) Способы стерилизации биологических материалов
DE60230869D1 (de) 4-(phenylpiperazinylmethyl) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen
MY141003A (en) Materials and methods for treating viral infections with a cysteamine compound
EA200000911A1 (ru) Новые кристаллические формы антивирусного соединения бензимидазола
DE602004032522D1 (de) Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung
BRPI0509140A (pt) processos para o tratamento de infecção por hiv
DE50110618D1 (de) Verwendung von MEK-Inhibitoren zur Herstellung eines Arzneimittels gegen Negativstrang-RNA-Viren Infektionen
DE112004000961D2 (de) Verwendung von Wirksubstanzen zur Vorbeugung oder Behandlung von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen
EA200200137A1 (ru) Лечение невротических нарушений
DE602006020775D1 (de) Verwendung von benzokondensierten heterocyclischen sulfamid-derivaten zur behandlung von manie und bipolaren störungen
DE60333205D1 (de) Histaminika zur behandlung von allergischer rhinitis
EA200200502A1 (ru) Способ введения ингибитора фосфодиэстеразы 4
DE60122541D1 (de) 2-Indanylaminoderivate zur Therapie von chronischen, akuten oder entzündlichen Schmerzen
DE60213234D1 (de) 4-(penylpiperidin-4-ylidenmethyl)benzamidderivate und deren verwendung zur behandlung von schmerzen, angstzuständen oder erkrankungen des magen-darm-trakts
ATE398134T1 (de) Neue analoga von nitrobenzylthioinosin
ATE268170T1 (de) Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz
DE602004009166D1 (de) Neue Analoga von Nitrobenzylthioinosin
BR0211533A (pt) Tratamento de dor crÈnica com 3-heterociclil- e 3-cicloalquil-3-ariloxipropanaminas
ATE332141T1 (de) Verwendung von 5-substituierten nukleosiden und/oder deren prodrugs zur resistenzfreien therapie von infektionskrankheiten
DE602004016547D1 (de) 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen
ATE371461T1 (de) Verwendung von extrakten aus wurzeln von pelargonium sidoides und/oder pelargonium reniforme
ATE544453T1 (de) Kombinationstherapien mit l-fmau zur behandlung von hepatitis-b-virus-infektionen
ATE478679T1 (de) Verfahren zur anwendung von ionisierungsstrahlung bei einer hiv-infektionstherapie
BR0211522A (pt) Tratamento de dor crÈnica com 3-arilóxi-3-fenilpropanaminas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1321139

Country of ref document: EP